Jazz Pharmaceuticals plc’s recent filing unveils that its Chairman & CEO COZADD BRUCE C unloaded Company’s shares for reported $0.24 million on Dec 02 ’24. In the deal valued at $121.17 per share,2,000 shares were sold. As a result of this transaction, COZADD BRUCE C now holds 427,025 shares worth roughly $52.84 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Carr Patricia sold 53 shares, generating $6,492 in total proceeds. Upon selling the shares at $122.49, the SVP, Chief Accounting Officer now owns 6,596 shares.
Before that, COZADD BRUCE C bought 2,000 shares. Jazz Pharmaceuticals plc shares valued at $242,340 were divested by the Officer at a price of $121.17 per share.
Morgan Stanley upgraded its Jazz Pharmaceuticals plc [JAZZ] rating to an Overweight from a an Equal-weight in a research note published on December 12, 2024; the price target was increased to $175 from $140. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Robert W. Baird began covering JAZZ with “an Outperform” recommendation on January 03, 2024. UBS revised its rating on November 27, 2023. It rated JAZZ as “a Neutral” which previously was an “a Buy”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -0.42% to $123.73. Over the last five days, the stock has gained 0.72%. Jazz Pharmaceuticals plc shares have risen nearly 0.30% since the year began. Nevertheless, the stocks have risen 1.75% over the past one year. While a 52-week high of $134.17 was reached on 02/26/24, a 52-week low of $99.06 was recorded on 07/10/24. SMA at 50 days reached $119.17, while 200 days put it at $112.79.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 121.74, which if violated will result in even more drops to 119.76. On the upside, there is a resistance level at 125.16. A further resistance level may holdings at 126.60. The Relative Strength Index (RSI) on the 14-day chart is 54.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.20%. Stochastics %K at 62.94% indicates the stock is a holding.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2024-11-29, growing by 0.66 million shares to a total of 4.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 3.59 million shares. There was a rise of 15.51%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 29, 2023 when Raymond James began covering the stock and recommended ‘”a Mkt perform”‘ rating .
